Cargando…
Post-COVID mRNA-vaccine IgG4 shift: worrisome?
COVID-19 vaccines play a key role in ending the pandemic. Unraveling the immunological phenomena involved in offering protective immunity is the cornerstone of achieving such success. This perspective evaluates the possible mechanisms and implications of IgG4 production in response to mRNA-based COV...
Autor principal: | Kadkhoda, Kamran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449502/ https://www.ncbi.nlm.nih.gov/pubmed/37191589 http://dx.doi.org/10.1128/msphere.00085-23 |
Ejemplares similares
-
Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development
por: Dumet, Christophe, et al.
Publicado: (2019) -
Human IgG and IgA responses to COVID-19 mRNA vaccines
por: Wisnewski, Adam V., et al.
Publicado: (2021) -
Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2021) -
IgG4-related Disease Emerging after COVID-19 mRNA Vaccination
por: Aochi, Satsuki, et al.
Publicado: (2023) -
Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)